Reyarc Participated in the Third Session of the Fifth General Assembly of Beijing Pharmaceutical Industry Association and the 4th Session of the Fifth Standing Council
Update time：2018-03-26 13:31:00 Views：
On the afternoon of March 16th, as a member of the Pharmaceutical Industry Association and a Standing Council, Reyarc participated in the Third Session of the Fifth General Assembly of Beijing Pharmaceutical Industry Association and the 4th Session of the Fifth Standing Council. The conference was successfully held in the lecture hall of Beijing Kangchen Pharmaceutical Co., Ltd. Leaders of Beijing economic and information technology commission, Food and Drug Administration, Social Work Committee, Chinese Medicine Bureau, Association Office, Industrial Economics Union, and many other fraternal unit attended the conference. Nearly 300 people from 200 member units attended the conference.
The conference was chaired by Fu Lijia, executive vice president of the Beijing Pharmaceutical Industry Association and general manager of Beijing Yadong Biopharmaceutical Co., Ltd.
At the third session of the Fifth General Assembly, the president of the Beijing Pharmaceutical Industry Association, Mei Qun, made the 2017 annual report of the association. The report takes the theme of "Practicing the spirit of the Nineteenth Party Congress and leading the industry towards new development"and summarizes the contents of the association's work in the previous year in four aspects.
One is to actively respond to changes in the situation with policy services. The second is to expand the association's service area with innovative ideas. The third is to fulfill their duties and practice the "Healthy China" strategy. The fourth is to promote the comprehensive construction of the association with the aid of party building.
After the membership meeting ended, more than 60 units continued to attend the 4th Session of the Fifth Standing Council. The meeting was presided over by the vice president of the association and the general manager of Beijing Huamiao Pharmaceutical Co., Ltd.
First of all, Secretary Zhou Yulan made a key job description for the association in 2018; at the meeting, it reviewed and approved the “Proposal for Requesting the Supplementary Selection of the Fifth Vice-President of the Council” and “Proposal for the Supplementary Selection of the Standing Director of the Fifth Board of Directors”. It supplemented the Beijing Kerui Bio-Technology Co., Ltd. and Beijing International Engineering Consulting Co., Ltd. as vice president units, and supplemented Beijing Kangchen Pharmaceutical Co., Ltd. and ZhongAohuiCheng Technology Co., Ltd. as the standing director units. Finally, Mei Qun, the president made a concluding statement, he emphasized that the time for the development of the pharmaceutical industry is a good time, the association must provide services for its member units, establish policy interactions, exhibitions, overseas exchange platforms, revitalize the pharmaceutical industry's stock, discover incrementals, and assist member companies in developing good companies. And the member companies should work hard together to promote the healthy development of the pharmaceutical industry. The conference ended successfully in an atmosphere of communication and learning.